Severity of PTSD symptoms linked to decreased activity in hippocampus

by Society for NeuroscienceFear-potentiated startle interacts with hippocampal threat reactivity in predicting PTSD at two-weeks. Credit: Tanriverdi et al.,JNeurosci2022After a trauma

Updated on: February 03,2024

Severity of PTSD symptoms linked to decreased activity in hippocampus

by Society for NeuroscienceFear-potentiated startle interacts with hippocampal threat reactivity in predicting PTSD at two-weeks. Credit: Tanriverdi et al.,JNeurosci2022After a trauma

Updated on:February 03,2024

Brain changes may fuel 'long COVID' anxiety, confusion

Credit: Pixabay/CC0 Public DomainHere's more evidence of the toll that COVID-19 takes on the human brain: A new study finds biomarkers of neuron damage and brain inflammation in the blood are asso

Updated on: February 18,2024

Brain changes may fuel 'long COVID' anxiety, confusion

Credit: Pixabay/CC0 Public DomainHere's more evidence of the toll that COVID-19 takes on the human brain: A new study finds biomarkers of neuron damage and brain inflammation in the blood are asso

Updated on:February 18,2024

Study reveals direct gut-brain communication via vagus nerve

Updated on: March 05,2025

Study reveals direct gut-brain communication via vagus nerve

Updated on:March 05,2025

When does the brain process reward and risk? Neuroscientists test a computational model

by Cynthia Eller,California Institute of TechnologyNeural activity in a region of the brain called the anterior insula could utilize a representation of RePE to then decode RiPE at a later time.

Updated on: March 28,2024

When does the brain process reward and risk? Neuroscientists test a computational model

by Cynthia Eller,California Institute of TechnologyNeural activity in a region of the brain called the anterior insula could utilize a representation of RePE to then decode RiPE at a later time.

Updated on:March 28,2024

Research team identifies new treatment target for Alzheimer's disease

byLancaster UniversityAlzheimer's disease is the leading cause of dementia and disability in old age. Credit: Lancaster UniversityResearchers at the University of Leeds and Lancaster Univers

Updated on: March 28,2024

Research team identifies new treatment target for Alzheimer's disease

byLancaster UniversityAlzheimer's disease is the leading cause of dementia and disability in old age. Credit: Lancaster UniversityResearchers at the University of Leeds and Lancaster Univers

Updated on:March 28,2024

Breakthrough in understanding the cause of a rare and life-threatening condition related to sleep apnea

byBen-Gurion University of the NegevGraphical abstract. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-023-00018-9Ben-Gurion University (BGU) of the Negev's Prof. Gad Vatine

Updated on: April 23,2024

Breakthrough in understanding the cause of a rare and life-threatening condition related to sleep apnea

byBen-Gurion University of the NegevGraphical abstract. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-023-00018-9Ben-Gurion University (BGU) of the Negev's Prof. Gad Vatine

Updated on:April 23,2024

Study maps brain wave disruptions affecting memory recall

by UT Southwestern Medical CenterTheta oscillations—brain waves associated with encoding memories—lessen in intensity with administration of a drug called scopolamine, according to a study by UT

Updated on: March 02,2024

Study maps brain wave disruptions affecting memory recall

by UT Southwestern Medical CenterTheta oscillations—brain waves associated with encoding memories—lessen in intensity with administration of a drug called scopolamine, according to a study by UT

Updated on:March 02,2024

Personal wealth associated with health care costs in people with Alzheimer's disease

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainFinland has a strong public health care system; nevertheless, personal wealth is associated with the costs of hospital care and me

Updated on: February 24,2024

Personal wealth associated with health care costs in people with Alzheimer's disease

by University of Eastern FinlandCredit: Pixabay/CC0 Public DomainFinland has a strong public health care system; nevertheless, personal wealth is associated with the costs of hospital care and me

Updated on:February 24,2024

Cure for male pattern baldness given boost by sugar discovery

byUniversity of SheffieldMicroscopic analysis of skin sections retrieved on day 21 of experiment after H&E staining. Credit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.20

Updated on: August 01,2024

Cure for male pattern baldness given boost by sugar discovery

byUniversity of SheffieldMicroscopic analysis of skin sections retrieved on day 21 of experiment after H&E staining. Credit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.20

Updated on:August 01,2024

Beyond neurons: How cells called astrocytes contribute to brain disorders

by Salk InstituteSalk researchers studied the molecules produced by astrocytes, like those pictured, to understand how the cells play a role in neurodevelopmental disorders. Credit: Salk Institut

Updated on: February 03,2024

Beyond neurons: How cells called astrocytes contribute to brain disorders

by Salk InstituteSalk researchers studied the molecules produced by astrocytes, like those pictured, to understand how the cells play a role in neurodevelopmental disorders. Credit: Salk Institut

Updated on:February 03,2024

Growth charts for the brain help to understand mental illness

by Radboud UniversityResearchers have developed growth charts for the brain as reference models for brain develpment and aging. Credit: Andre MarquandResearchers from Radboudumc have developed a

Updated on: February 21,2024

Growth charts for the brain help to understand mental illness

by Radboud UniversityResearchers have developed growth charts for the brain as reference models for brain develpment and aging. Credit: Andre MarquandResearchers from Radboudumc have developed a

Updated on:February 21,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on: April 02,2024

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Updated on:April 02,2024